ESTIMATING THE POTENTIAL BUDGET IMPACT OF ZELBORAF (VEMURAFENIB) FOR ADVANCED MELANOMA TREATMENT IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：0

作者：

Tsuchiya, C. T. ^{[1
]}

Buschinelli, C. T. ^{[1
]}

Maximo, M. F. M. ^{[1
]}

Tobaruella, F. S. ^{[1
]}

Borges, L. G. ^{[1
]}

机构：

[1] Roche Brazil, Sao Paulo, Brazil

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

10.1016/j.jval.2013.03.641

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A132 / A132

页数：1

共 50 条

[31] BUDGET IMPACT ANALYSIS OF TOFACITINIB FOR RHEUMATOID ARTHRITIS FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Ferreira, C. N.
Rufino, C. S.
Santana, C. F.
Dulcine, M.
VALUE IN HEALTH, 2015, 18 (07) : A638 - A638
[32] METASTATIC BREAST CANCER TREATMENT PATTERNS AND COSTS OF OUTPATIENT CARE UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
Teich, V
Teich, N.
Nita, M.
Donato, B. M.
Rached, R.
Rahal, E.
VALUE IN HEALTH, 2009, 12 (07) : A493 - A494
[33] BUDGET IMPACT OF DURVALUMAB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE STAGE III NONSMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Meirelles, I
Costa, N.
Dias, C.
Massaoka, M.
Lopes, D. G.
Jabase, L.
VALUE IN HEALTH, 2023, 26 (12) : S125 - S125
[34] COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF UPADACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Acayaba de Toledo, R.
Arruda, M. S.
Morais, C. G., V
dos Santos, R.
VALUE IN HEALTH, 2021, 24 : S16 - S17
[35] PUBLIC HEALTH AND ECONOMIC IMPACT OF VACCINATION OF SENIORS WITH A HIGH DOSE TRIVALENT INFLUENZA VACCINE IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM
Boiron, L.
Araujo, R. R.
VALUE IN HEALTH, 2019, 22 : S644 - S645
[36] THE IMPACT OF BIOLOGIC THERAPY VERSUS CONVENTIONAL TREATMENT ON THE COSTS OF ANKYLOSING SPONDYLITIS CHRONIC COMPLICATIONS UNDER THE PERSPECTIVE OF BRAZILIAN PRIVATE HEALTH CARE SYSTEM
Menezes, F. G.
Chibana, V
Tolentino, A. C.
Reis, F. H.
VALUE IN HEALTH, 2015, 18 (07) : A641 - A641
[37] Target therapy versus dacarbazine in first-line treatment of advanced non-surgical and metastatic melanoma: budget impact analysis from the perspective of the Brazilian National Health System, 2018-2020
Correa, Flavia de Miranda
Guerra, Renata Leborato
Alves Fernandes, Ricardo Ribeiro
de Souza, Mirian Carvalho
Zimmermann, Ivan Ricardo
EPIDEMIOLOGIA E SERVICOS DE SAUDE, 2019, 28 (02):
[38] ANALYSIS OF ORCHAMINAL IMPACT OF CRIZOTINIBE IN THE TREATMENT OF LUNG CANCER IN SMALL ALK-POSITIVE ADVANCED CELLS UNDER THE PERSPECTIVE OF THE PRIVATE BRAZILIAN HEALTH SYSTEM
Alexandre, R. F.
Squiassi, H. B.
Santana, C. F.
VALUE IN HEALTH, 2017, 20 (09) : A873 - A873
[39] BUDGET IMPACT ANALYSIS OF ELTROMBOPAG OLAMINA FOR IMMUNE THROMBOCYTOPENIA (ITP) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS)
Kim, H.
Shamilian, G.
Bertinato, J. F.
VALUE IN HEALTH, 2020, 23 : S523 - S523
[40] BUDGET IMPACT ANALYSIS OF ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PREVIOUSLY TREATED WITH DOCETAXEL FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
Vitale, V.
Asano, E.
Pereira, M. L.
VALUE IN HEALTH, 2013, 16 (07) : A665 - A665

← 1 2 3 4 5 →